Immunotherapies targeting tau in mouse models of human tauopathies could have disease-modifying effects. In this issue of Neuron, Yanamandra et al. (2013) use tau antibodies, which effectively block tau seeding in culture, to attenuate tauopathy and improve cognition in mutant tau mouse models
Alzheimer’s disease (AD) is the leading cause of dementia, accounting for 50 to 80 percent of dement...
Tauopathies are characterized by the progressive accumulation of hyperphosphorylated, aggregated for...
Abstract Background Accumulati...
Immunotherapies targeting tau in mouse models of human tauopathies could have disease-modifying effe...
SummaryTau aggregation occurs in neurodegenerative diseases including Alzheimer’s disease and many o...
BACKGROUND: The accumulation of pathological tau is the main component of neurofibrillary tangles an...
Tau neuronal and glial pathologies drive the clinical presentation of Alzheimer’s disease and relate...
Marie Albert, Georges Mairet-Coello, Luc Buée and Morvane Colin : these author contributed equally t...
Neurofibrillary pathology comprised of pathological tau protein is closely tied to a range of neurod...
The amyloid β (Aβ)-protein and microtubule-associated protein, tau, are the major components of the ...
The amyloid β (Aβ)-protein and microtubule-associated protein, tau, are the major components of the ...
Abstract Background Accumulating evidence indicates that Tau pathology can spread from neuron to neu...
In Alzheimer's disease (AD), an extensive accumulation of extracellular amyloid plaques and intraneu...
Tau, the main component of the neurofibrillary tangles (NFTs), is an attractive target for immunothe...
In Alzheimer's disease (AD) brains, the microtubule-associated protein tau and amyloid-β (Aβ) deposi...
Alzheimer’s disease (AD) is the leading cause of dementia, accounting for 50 to 80 percent of dement...
Tauopathies are characterized by the progressive accumulation of hyperphosphorylated, aggregated for...
Abstract Background Accumulati...
Immunotherapies targeting tau in mouse models of human tauopathies could have disease-modifying effe...
SummaryTau aggregation occurs in neurodegenerative diseases including Alzheimer’s disease and many o...
BACKGROUND: The accumulation of pathological tau is the main component of neurofibrillary tangles an...
Tau neuronal and glial pathologies drive the clinical presentation of Alzheimer’s disease and relate...
Marie Albert, Georges Mairet-Coello, Luc Buée and Morvane Colin : these author contributed equally t...
Neurofibrillary pathology comprised of pathological tau protein is closely tied to a range of neurod...
The amyloid β (Aβ)-protein and microtubule-associated protein, tau, are the major components of the ...
The amyloid β (Aβ)-protein and microtubule-associated protein, tau, are the major components of the ...
Abstract Background Accumulating evidence indicates that Tau pathology can spread from neuron to neu...
In Alzheimer's disease (AD), an extensive accumulation of extracellular amyloid plaques and intraneu...
Tau, the main component of the neurofibrillary tangles (NFTs), is an attractive target for immunothe...
In Alzheimer's disease (AD) brains, the microtubule-associated protein tau and amyloid-β (Aβ) deposi...
Alzheimer’s disease (AD) is the leading cause of dementia, accounting for 50 to 80 percent of dement...
Tauopathies are characterized by the progressive accumulation of hyperphosphorylated, aggregated for...
Abstract Background Accumulati...